Boletín de estupefacientes

• 

  Año 2001, Vol. 53, Número 1-2

  • Seleccionado

    The need for dynamic models of drug markets1

    P. Reuter

    • Resumen
    • Texto completo
    
  • Seleccionado

    The dynamic character of drug problems

    J.P. Caulkins

    • Resumen
    • Texto completo
    
  • Seleccionado

    Key variables and data requirements in modelling drug systems

    E. Single

    • Resumen
    • Texto completo
    
  • Seleccionado

    A mover-stayer type model for epidemics of problematic drug use

    C. Rossi

    • Resumen
    • Texto completo
    
  • Seleccionado

    The dynamic process of dynamic modelling: the cocaine epidemic in the United States of America

    Doris Behrens-Abouseif, Gernot Tragler

    • Resumen
    • Texto completo
    
  • Seleccionado

    Pharmaco-economics of drug addiction: estimating the costs of hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection among injecting drug users in member States of the European Union*

    M. J. Postma, Lambert Wiesing, Johannes C. Jager

    • Resumen
    • Texto completo
    
  • Seleccionado

    Controlling infectious diseases among injection drug users: learning (the right) lessons from acquired immunodeficiency syndrome (AIDS)

    Henry Pollack

    • Resumen
    • Texto completo
    
  • Seleccionado

    Age-specific multi-state drug initiation models: insights from considering heterogeneity*

    C. Almeder, J.P. Caulkins, G. Feichtinger, Gernot Tragler

    • Resumen
    • Texto completo
    
  • Seleccionado

    The epidemiology of drug use at the macro level: indicators, models and policy-making*

    Lambert Wiesing, R. Hartnoll, C. Rossi

    • Resumen
    • Texto completo
    
  • Seleccionado

    Incidence indicators for policy-making: models, estimation and implications

    L. Ravà, M.G. Calvani, S. Heisterkamp, Lambert Wiesing, C. Rossi

    • Resumen
    • Texto completo